Avicanna Reports Q3 2025
TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (Avicanna or Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commerc…
November 15, 2025